KIDRON NADAV
SEC insider (Form 3/4/5 filer). CIK 0001351779. President and CEO at ORAMED PHARMACEUTICALS INC. (ORMP) and 3 other issuers. 20 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in NEW YORK, NY.
Companies KIDRON NADAV has filed insider reports for
- ORAMED PHARMACEUTICALS INC. (ORMP): Director, Officer, President and CEO
- Nano Dimension Ltd. (NNDM): Director
- Lifeward Ltd. (LFWD): Director
- Alpha Tau Medical Ltd. (DRTS): Director
KIDRON NADAV
CIK: 0001351779
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect368.8K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
196.5K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
107K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
150K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
97K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
49K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
DispositionDirectStock option (right to buy)
190K shares- - Sep 24, 2026ORMP
ORAMED PHARMACEUTICALS INC.
AwardDirect349.5K shares- - Aug 21, 2026NNDM
Nano Dimension Ltd.
In-the-MoneyDirect10K shares at avg. $1.50$15K - Mar 25, 2026LFWD
Lifeward Ltd.
AwardDirect7.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 |  ORMP ORAMED PHARMACEUTICALS INC. | Award | 368,765 | - | $0 | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 196,500 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 107,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 150,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 97,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 49,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Disposition Stock option (right to buy) | 190,000 | - | - | Direct |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | Award | 349,497 | - | $0 | Direct |
| Aug 21, 2026 |  NNDM Nano Dimension Ltd. | In-the-Money | 10,000 | $1.50 | $15,000 | Direct |
| Mar 25, 2026 |  LFWD Lifeward Ltd. | Award | 7,657 | - | $0 | Direct |
1-10 of 20 transactions